Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA.

HoJin ShinSebastian SchneeweissRobert J GlynnElisabetta Patorno

Published in: Diabetes care (2021)

Among adult patients with type 2 diabetes, metformin was by far the most frequent first-line treatment. While the use of SGLT-2i and GLP-1RA was low from 2013 through 2019, it increased among patients with CVD.

Keyphrases

rheumatoid arthritis
disease activity
ankylosing spondylitis
blood glucose
interstitial lung disease
systemic lupus erythematosus
type diabetes
adipose tissue
blood pressure
metabolic syndrome
systemic sclerosis